Both in Pharmaceuticals
Kyntra Bio vs Marker Therapeutics
Over the past year KYNB returned −50.3% and MRKR returned −51.7%; their daily moves had a correlation of 0.16.
KYNB −50.3% MRKR −51.7%Growth of $1, one year, split-adjusted
| Metric | KYNB | MRKR |
|---|---|---|
| Price | $4.72 | $1.00 |
| Market cap | $19.1M | $16.7M |
| Today | +4.89% | +5.12% |
| 1 month | −30.5% | −9.1% |
| 6 months | −33.0% | −31.0% |
| Year to date | — | −32.9% |
| 1 year | — | −2.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 7.1× |
| Net cash | $91.3M | $11.3M |
| Dividend yield | — | — |
| Volatility (60d) | 56.1% | 83.4% |
| Short % of float | 2.5% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).